Centaurus Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,215
| Closed | -$416K | – | 932 |
|
|
2024
Q3 | $416K | Buy |
+4,215
| New | +$416K | 0.03% | 452 |
|
|
2024
Q2 | – | Sell |
-19,864
| Closed | -$1.89M | – | 850 |
|
|
2024
Q1 | $1.89M | Buy |
19,864
+6,456
| +48% | +$613K | 0.13% | 154 |
|
|
2023
Q4 | $1.2M | Buy |
+13,408
| New | +$1.2M | 0.09% | 209 |
|
|
2023
Q3 | – | Sell |
-1,880
| Closed | -$156K | – | 809 |
|
|
2023
Q2 | $156K | Buy |
+1,880
| New | +$156K | 0.01% | 625 |
|
|
2023
Q1 | – | Sell |
-3,704
| Closed | -$307K | – | 946 |
|
|
2022
Q4 | $307K | Sell |
3,704
-380
| -9% | -$31.5K | 0.03% | 481 |
|
|
2022
Q3 | $324K | Sell |
4,084
-20,198
| -83% | -$1.6M | 0.03% | 461 |
|
|
2022
Q2 | $1.8M | Buy |
+24,282
| New | +$1.8M | 0.18% | 150 |
|
|
2021
Q4 | – | Sell |
-31,241
| Closed | -$3.93M | – | 978 |
|
|
2021
Q3 | $3.93M | Buy |
31,241
+20,561
| +193% | +$2.58M | 0.33% | 70 |
|
|
2021
Q2 | $1.45M | Buy |
10,680
+1,299
| +14% | +$176K | 0.12% | 202 |
|
|
2021
Q1 | $1.27M | Buy |
9,381
+8,130
| +650% | +$1.1M | 0.13% | 199 |
|
|
2020
Q4 | $176K | Buy |
+1,251
| New | +$176K | 0.02% | 586 |
|
|
2020
Q3 | – | Sell |
-1,605
| Closed | -$180K | – | 701 |
|
|
2020
Q2 | $180K | Buy |
+1,605
| New | +$180K | 0.03% | 452 |
|
|
2020
Q1 | – | Sell |
-9,509
| Closed | -$904K | – | 663 |
|
|
2019
Q4 | $904K | Buy |
+9,509
| New | +$904K | 0.13% | 192 |
|
|
2018
Q3 | – | Sell |
-4,354
| Closed | -$414K | – | 2058 |
|
|
2018
Q2 | $414K | Sell |
4,354
-10,224
| -70% | -$972K | 0.06% | 345 |
|
|
2018
Q1 | $1.28M | Buy |
14,578
+581
| +4% | +$51K | 0.3% | 85 |
|
|
2017
Q4 | $1.19M | Buy |
+13,997
| New | +$1.19M | 0.31% | 88 |
|